sertraline and Local Neoplasm Recurrence
sertraline has been researched along with Local Neoplasm Recurrence in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Al-Janabi, H; Au, P; Barnes, NM; Barnes, TRE; Birchwood, M; Drake, R; Giacco, D; Griffiths, SL; Husain, N; Katshu, MZUH; Major, B; Marriott, C; Ottridge, R; Palmer, ER; Patel, S; Sadiq, Z; Taylor, E; Tearne, S; Upthegrove, R; Walters, JTR; Watkins, B; Weetman, T; Woolley, R | 1 |
Girgis-Gabardo, A; Gwynne, WD; Hassell, JA; Shakeel, MS | 1 |
Boockvar, JA; Brüning, A; Cappello, F; Chang, WW; Cvek, B; Dou, QP; Duenas-Gonzalez, A; Efferth, T; Focosi, D; Ghaffari, SH; Halatsch, ME; Karpel-Massler, G; Kast, RE; Keizman, D; Ketola, K; Khoshnevisan, A; Magné, N; Marosi, C; McDonald, K; Muñoz, M; Paranjpe, A; Pourgholami, MH; Sardi, I; Sella, A; Srivenugopal, KS; Tuccori, M; Wang, W; Wirtz, CR | 1 |
Halatsch, ME; Karpel-Massler, G; Kast, RE | 1 |
Ahmed, A; Armaiz-Pena, GN; Bender, D; Christensen, DK; DeGeest, K; Domann, F; Goodheart, MJ; Lutgendorf, SK; Matsuo, K; Mendez, L; Penedo, FJ; Ramirez, E; Shinn, E; Sood, AK; Thaker, PH; Zand, B; Zimmerman, B | 1 |
Reviews
2 review(s) available for sertraline and Local Neoplasm Recurrence
Article | Year |
---|---|
The Role of Serotonin in Breast Cancer Stem Cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Docetaxel; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplastic Stem Cells; Phenotype; Receptors, Serotonin; Remission Induction; Serotonin; Sertraline; Signal Transduction | 2021 |
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Auranofin; Brain Neoplasms; Captopril; Dacarbazine; Disulfiram; Glioblastoma; Gluconates; Humans; Ketoconazole; Morpholines; Nelfinavir; Neoplasm Recurrence, Local; Sertraline; Succinates; Temozolomide | 2013 |
Trials
1 trial(s) available for sertraline and Local Neoplasm Recurrence
Article | Year |
---|---|
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial.
Topics: Adult; Antidepressive Agents; Child, Preschool; Depression; Humans; Infant; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Psychotic Disorders; Quality of Life; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2023 |
Other Studies
2 other study(ies) available for sertraline and Local Neoplasm Recurrence
Article | Year |
---|---|
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Artesunate; Auranofin; Brain Neoplasms; Captopril; Celecoxib; Dacarbazine; Disulfiram; Glioblastoma; Humans; Itraconazole; Molecular Targeted Therapy; Morpholines; Neoplasm Recurrence, Local; Pyrazoles; Ritonavir; Sertraline; Signal Transduction; Sulfonamides; Temozolomide; Treatment Outcome | 2014 |
SSRI use and clinical outcomes in epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antidepressive Agents, Second-Generation; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Chi-Square Distribution; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Mice, Nude; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Odds Ratio; Ovarian Neoplasms; Proportional Hazards Models; Receptor, Serotonin, 5-HT2A; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Time Factors; Tumor Microenvironment; United States; Up-Regulation; Xenograft Model Antitumor Assays | 2016 |